Dan Lynch
InvestorExecutive Venture Partner at GV (Google Ventures) · Executive at SpringWorks Therapeutics
Boston, Massachusetts
Writes $250K – $50M checks · typically $25M
Find your path to Dan
178 people in our graph share verified history with Dan — schools, employers, funds. One of them is your warm intro.
About
Dan Lynch joined GV as an Executive Venture Partner and senior member of the life sciences team, in a newly created role focused on coaching CEOs and executives at emerging life sciences companies, identifying new investments, and mentoring the firm's life sciences team. He has spent decades in biotech as a CFO, CEO, and executive chairman, and has served as a board member or board chair of 16 companies since 2011. His work centers on advising biotech founders on talent, fundraising, and business development.
Likely email· guessed from name + firm domain, not firm-published
- d•••@gv.comreveal100% confident
Invests in
BiotechDigital HealthMedical Devices
Executive at SpringWorks Therapeutics
Intro paths
In turn, Dan can intro founders to SpringWorks Therapeutics's investors below.
SpringWorks Therapeutics's investors · 3
Experience
- Xilio, SpringWorks, bluebird, Blueprint, TranslateChairman of the Boardcurrent2008 — present
- Xilio Therapeutics, Inc.Chairman Of The Boardcurrent2020 — present
- SpringWorks TherapeuticsChairman of the Boardcurrent2017 — presentstamford, ct
- Blueprint MedicinesChairman Of The Boardcurrent2012 — presentCambridge, MA
- Translate BioChairman Of The Boardcurrent2012 — presentCambridge, MA
Investments
Board seats
2Seventy BioAlpha Omega SPACAvila TherapeuticsBIND BiosciencesBlueprint MedicinesEdimer PharmaceuticalseGenesis BioEmber TherapeuticsNimbus DiscoveryProclara BiosciencesSesen BioSpringWorks TherapeuticsStromedixSurface OncologyXilio Therapeutics
Per the firm's website.
Colleagues at GV (Google Ventures)
Network10
Investors connected to Dan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dan Lynch?
- Dan Lynch joined GV as an Executive Venture Partner and senior member of the life sciences team, in a newly created role focused on coaching CEOs and executives at emerging life sciences companies, identifying new investments, and mentoring the firm's life sciences team. He has spent decades in biotech as a CFO, CEO, and executive chairman, and has served as a board member or board chair of 16 companies since 2011. His work centers on advising biotech founders on talent, fundraising, and business development.
- Where does Dan Lynch work?
- Dan Lynch is Executive Venture Partner at GV (Google Ventures) and Executive at SpringWorks Therapeutics.
- What does Dan Lynch invest in?
- Dan Lynch invests in Biotech, Digital Health, Medical Devices.
- What check size does Dan Lynch write?
- Dan Lynch typically writes checks of $250K – $50M.
- What boards does Dan Lynch sit on?
- Dan Lynch holds tracked board seats at 2Seventy Bio, Alpha Omega SPAC, Avila Therapeutics, BIND Biosciences, Blueprint Medicines, Edimer Pharmaceuticals, eGenesis Bio, Ember Therapeutics, Nimbus Discovery, Proclara Biosciences.
- Where did Dan Lynch go to school?
- Dan Lynch studied at University of Virginia Darden School of Business (MBA); Wesleyan University (Bachelor of Arts (B.A.), Mathematics).
Same school
Also attended University of Virginia Darden School of Business178
+ 172 more
Also attended Wesleyan University112
+ 106 more
Shared employers
Also worked at Xilio Therapeutics, Inc.7
+ 1 more
Also worked at SpringWorks Therapeutics1
Also worked at Blueprint Medicines9
+ 3 more
